Insights into Company Bills & Payments

Axiscades Technologies Limited

📍 Bengaluru, Karnataka, India Active NSE AXISCADES CIN L72200KA1990PLC084435 IT Services & Software
Search companies

Key Metrics of Axiscades Technologies Limited

Revenue₹455 Cr▲ 14.4% YoYFY 2025-26
EBITDA₹61.6 Cr▼ 22.6% YoY
Net profit₹11.2 Cr▼ 72.5% YoY
Net worth₹402 Cr▲ 2.4% YoY
Competitors10identified

About Axiscades Technologies Limited

Sectors

Heavy Engineering & Capital GoodsCapital Goods & Power EquipmentIT Services & SoftwareIndian IT Services

Company details

Registered office
Block C Second Floor Kirloskar Business Park, Hebbal Bangalore, Bengaluru, In-ka, 560024
Listed
NSE: AXISCADES · ₹1,875.90

Operational Areas of Axiscades Technologies Limited

Heavy Engineering & Capital Goods›Capital Goods & Power Equipment
IT Services & Software›Indian IT Services

Company summary

Entity details

CINL72200KA1990PLC084435
LEI code335800KHE667P5ZJOL65
State codeKA
PIN code560024
Current legal nameAXISCADES TECHNOLOGIES LIMITED
Classification—
Listing statusListed (NSE: AXISCADES)
Registration no.084435
Company age—
PAN—
CountryIndia
CityBengaluru
StateKarnataka
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueMGT-7 for FY 2025-26 · 29 Nov 2026

Industry classification

NIC code72200
Description of main activityComputer and related activities (software, IT services)
Description of business activityComputer and related activities (software, IT services)
SectorIT Services & Software · Indian IT Services

Share price · NSE: AXISCADES

AXISCADES on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date passed
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 27 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 23 Jun 2026 CARE A- Developing outlook · Short term A2+ · Watch
Change in last 12 monthsNo change
Change since first rating on record▲ 1 notchsince Jan 2018
Rating actions150 up · 0 down
Liquidity (CARE)Adequate

NoteRating watch (CARE, 23 Jun 2026)

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
23 Jun 2026CAREWatch A-A2+Developing₹101 Cr View
02 Jun 2026CAREOther ———— View
06 Oct 2025CAREOther ———— View
04 Oct 2024CAREReaffirmed A-A2+Stable₹101 Cr View
17 Apr 2024CARERevised (from BBB+) A-—Stable₹61.0 Cr View
10 Aug 2023CARERevised (from BBB) BBB+—Stable₹61.5 Cr View
25 Jan 2023CAREWatch BBB—Stable₹59.5 Cr View
27 Dec 2022CAREOther ———— View
22 Aug 2022CAREWatch BBBA3Developing₹59.5 Cr View
24 Jan 2022CAREWatch BBBA3Developing₹92.8 Cr View
03 Nov 2020CAREWatch BBBA3Developing₹199 Cr View
03 Jan 2020CAREReaffirmed (from BBB) BBBA3Stable₹209 Cr View
07 Feb 2019CARERevised (from BBB+) BBBA3+Negative₹110 Cr View
21 Aug 2018CARERevised BBB+A3+Negative₹86.8 Cr View
05 Jan 2018CAREWatch BBB+A3+Stable₹86.8 Cr View

Credit strengths (CARE, Jun 2026)

+ Funding arranged for ongoing and upcoming investment plans

Post management change in Q3FY25 when Dr. Sampath Ravinarayan returned as Chairman and Managing Director (CMD) of the company, he launched Power 930 programme for the company , targeting revenue base of ₹9000 crore and PAT of ₹960 crore by FY30. This was planned to be achieved by restructuring of existing business and change of portfolio mix by moving organisation from predominantly service led company into a focused manufacturing and product-driven enterprise operating in high-growth

+ Consistent improvement in operational performance

The company’s total operating income (TOI) increased to ₹1,159 crore in FY26 from ₹1,031 crore in FY25, supported by addition of new clients across multiple verticals, and an improvement in the order book position. Engineering service businesses proposed to be divested accounted for ~55% of the company’s total revenue in FY26. Despite the proposed divestment of these businesses, the company is expected to register revenue growth of ~10% in FY27, driven by a higher executable order book in defenc

+ Established operational track record supported by marquee customers

ACTL commenced operation from 1990 and has over two decades of satisfactory track record of operations. Satisfactory execution of awarded projects enabled the company to establish its credentials in acquiring marquee customers and repeat orders over th e years, which has been its core strength. CareEdge Ratings notes that the company plans to leverage its long -standing relationships with leading original equipment manufacturer (OEM) s, developed in the last 15–20 years, to strengthen business d

Credit challenges

− Execution and stabilisation risks associated with ongoing and upcoming investments

The company is currently in the transformation phase and has aggressive capex and acquisition plans. In the next 3-4 years, company cumulatively plans to spend over ₹2200 crore towards these investments. Greenfield expansions are inherently exposed to execution and stabilisation risks while smooth transition of businesses proposed to be acquired in ACTL’s ecosystem also remains to be seen. ACTL has strengthened its leadership team by appointing experienced business heads with deep expertise

Could lead to an upgrade

• Improving revenues beyond ₹1,500 crore, net worth of over ₹800 crore, while maintaining total debt/profit before interest, lease rentals, depreciation, and taxation (TD/PBILDT) of less than 1x. 1Complete definition of ratings assigned are available at www.careratings.com and other CARE Ratings Limited’s publications. 1 CARE Ratings Ltd. Press Release

Could lead to a downgrade

• Declining revenues below ₹1,000 crore or TD/profit before depreciation, interest, and taxes (TD/PBDIT) of over 1.5x. • Overall gearing exceeding 1x.

Agency-reported financials (CARE, 23 Jun 2026)

MetricMarch 31, 2025March 31, 2026
Total operating income₹1,031 Cr₹1,159 Cr
PBILDT*₹145 Cr₹178 Cr
Profit after tax (PAT)₹75.28 Cr₹72.07 Cr
Overall gearing (x)0.39×0.71×
Interest coverage (x)4.33×5.73×
Revenue growth (YoY)—12.4%
PAT margin7.3%6.2%

Borrowings & rated debt

Rated borrowing limits (latest)₹101 Cr
Peak rated limits₹209 CrJan 2020 · CARE
Limits raised0 times0 new facilities rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
crore) Long-term bank facilities (RWD)Working capital & bank lines—₹21.0 Cr— A-WatchCARE
Long-term Short-term bank facilities (RWD)Working capital & bank lines—₹80.0 Cr— A- / A2+WatchCARE

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
Bank Guarantee₹1.00 CrCARE A- (Rating Watch with Developing Implications)
CC/Packing Credit₹80.0 CrCARE A- / CARE A2+ (Rating Watch with Developing Implications)
Loan Equivalent Risk—Withdrawn
Term Loan₹20.0 CrCARE A- (Rating Watch with Developing Implications)

Lenders

Fund-based - LTTerm LoanHDFC Bank Ltd.
Fund-based - LTTerm LoanRBL Bank Limited
Fund-based - LT/ STCC/Packing CreditHDFC Bank Ltd.
Fund-based - LT/ STCC/Packing CreditHSBC Ltd.
Fund-based - LT/ STCC/Packing CreditRBL Bank Limited
Non-fund-based - LTBank GuaranteeHDFC Bank Ltd.

Credit assessment · Services

Rating Methodology – Service Sector Companies · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityPoorAgency: Adequate
DirectionRating watch – DevelopingAgency outlook: Developing
CARE rating · Jun 2026A-1 notch above indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)58%
Information on file78% · missing: Capex / investment plans, Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further funding possible with conditions Next rating action stable or better: 57% (At risk of downgrade) · ML model on 6893 rating histories, AUC 0.653
Rated limits₹101 Cr
Not yet allocated—
Extra debt within 3.5× EBITDA—
Interest coverage5.73×
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 57% chance the next rating action is stable or better
  • Current rating A- (investment grade)
  • Interest coverage 5.73×

What happened, step by step

Refinanced bank debt with equity
  1. Apr 2024 — Full repayment of NCD
  2. Oct 2024 — ₹203 cr raised through equity

“Improvement in capital structure following fund raise through QIP ACTL raised net proceeds of ₹203 crore through QIP issue in the month of January 2024 of which ₹158 crore was earmarked for debt repayment while balance ₹45 crore is for utilisation towards general corporate purpose.”

Refinanced bank debt with NCDs / bonds
  1. Apr 2024 — ₹203 cr raised through NCDs / bonds
  2. Apr 2024 — Full repayment of NCD

“Of net proceeds of ₹203 crore raised through QIP, the company has repaid its high-cost non-convertible debentures (NCD) to the extent of ₹105 crore in March 2024 and another ₹53 crore is expected be repaid by December 31, 2024.”

Refinanced bank debt with NCDs / bonds from ACTL
  1. Aug 2022 — ₹100 cr raised through NCDs / bonds from ACTL
  2. Aug 2022 — Full repayment of NCDs

“CARE Ratings takes note of the non-convertible debentures (NCD) of ₹100 crore raised by ACTL to fund the Phase-III and Phase-IV of acquisition and will continue to monitor the further acquisition process and its implication on ACTL’s credit profile.”

Rated limits by facility

Timeline

23 Jun 2026 CARE watch: A- (Developing)Rated limits ₹101 cr CARE rationale
23 Jun 2026 Cash & liquid funds ₹45.46 cr
From the report

On a consolidated basis, ACTL had total cash and cash equivalent of ₹45.46 crore as on March 31, 2026.

CARE rationale
02 Jun 2026 CARE other: — CARE rationale
06 Oct 2025 CARE other: — CARE rationale
06 Oct 2025 Cash & liquid funds ₹97.4 cr
From the report

On consolidated basis, ACTL had cash and bank balances without lien of ₹97.40 crore as on March 31, 2025 and investment in mutual funds, among others, of ₹29.00 crore.

CARE rationale
04 Oct 2024 CARE reaffirmed: A- (Stable)Rated limits ₹101 cr CARE rationale
04 Oct 2024 ₹203 cr raised through equity
From the report

Improvement in capital structure following fund raise through QIP ACTL raised net proceeds of ₹203 crore through QIP issue in the month of January 2024 of which ₹158 crore was earmarked for debt repayment while balance ₹45 crore is for utilisation towards general corporate purpose.

CARE rationale
17 Apr 2024 CARE revised: A- (Stable)Rated limits ₹61 cr CARE rationale
17 Apr 2024 ₹203 cr raised through NCDs / bonds
From the report

Of net proceeds of ₹203 crore raised through QIP, the company has repaid its high-cost non-convertible debentures (NCD) to the extent of ₹105 crore in March 2024 and another ₹53 crore is expected be repaid by December 31, 2024.

CARE rationale
17 Apr 2024 ₹203 cr raised through equity
From the report

Detailed description of the key rating drivers: Key strengths Improvement in capital structure following fund raise through QIP: ACTL raised net proceeds of ₹203 crore through QIP issue in the month of January 2024 of which ₹158 crore is earmarked for debt repayment while balance ₹45 crore is for utilisation towards general corporate purpose.

CARE rationale
17 Apr 2024 Full repayment of NCD (₹105 cr)
From the report

Press Release repayment, the company has already pre-repaid NCD to the tune of ₹105 crore while balance amount of ₹53 crore would be prepaid by December 31, 2024.

CARE rationale
17 Apr 2024 Cash & liquid funds ₹275 cr
From the report

On consolidated basis, ACTL had cash and cash equivalents of ₹275 crore as on January 31, 2024, though is expected to be lower on March 31, 2024, as certain amount would have been utilised for NCD prepayments.

CARE rationale
10 Aug 2023 CARE revised: BBB+ (Stable)Rated limits ₹61.45 cr CARE rationale
10 Aug 2023 New borrowing arranged (NCDs / bonds)
From the report

CARE Ratings Limited (CARE Ratings) takes note ofrefinancing of the high- cost non-convertible debentures (NCDs), which were availed acquisition of Mistral, with a relatively low-cost borrowings and for slightly longer tenor.

CARE rationale
10 Aug 2023 Cash & liquid funds ₹109.4 cr
From the report

On a consolidated basis, ACTL’s cash and bank balances stood at around ₹109.4 crore as on March 31, 2023, as against minimal principal repayment obligations during FY24.

CARE rationale
10 Aug 2023 Cash & liquid funds ₹16.8 cr
From the report

On a standalone basis, ACTL’s cash and bank balances stood at ₹16.8 crore as on March 31, 2023.

CARE rationale
25 Jan 2023 CARE watch: BBB (Stable)Rated limits ₹59.45 cr CARE rationale
25 Jan 2023 ₹45 cr raised through NCDs / bonds
From the report

CARE Ratings Limited (CARE Ratings) takes note of the completion of Phase II by way of cash consideration of ₹72.13 crore, which has been funded using the ₹45 crore of additional non-convertible debentures (NCDs) raised, and balance using the promoters’ funds and internal accruals, as against the earlier expectation of completion of Phase II using shares allocation.

CARE rationale
25 Jan 2023 Cash & liquid funds ₹72.13 cr
From the report

CARE Ratings Limited (CARE Ratings) takes note of the completion of Phase II by way of cash consideration of ₹72.13 crore, which has been funded using the ₹45 crore of additional non-convertible debentures (NCDs) raised, and balance using the promoters’ funds and internal accruals, as against the earlier expectation of completion of Phase II using shares allocation.

CARE rationale
25 Jan 2023 ₹145 cr raised through NCDs / bonds
From the report

Key weaknesses Refinancing risk associated with NCD To pay out the consideration involved for Phase-II to Phase-IV of acquisition of Mistral, ACTL has raised NCD of ₹145 crore of tenor of one-three years.

CARE rationale
25 Jan 2023 Cash & liquid funds ₹80 cr
From the report

Liquidity: Adequate On a consolidated basis, ACTL’s cash and bank balances stood at around ₹80 crore as on December 31, 2022, as against principal repayment obligations of less than ₹10 crore for Q4FY23.

CARE rationale
25 Jan 2023 Cash & liquid funds ₹11.46 cr
From the report

On a standalone basis, ACTL’s and ACAT’s cash and bank balances stood at ₹11.46 crore and ₹5.61 crore, respectively, as on December 31, 2022.

CARE rationale
25 Jan 2023 Cash & liquid funds ₹40 cr
From the report

With expected overall gearing of less than 1.0x and cash accruals of more than ₹40 crore, the company has adequate headroom to raise additional debt in case required.

CARE rationale
27 Dec 2022 CARE other: — CARE rationale
22 Aug 2022 CARE watch: BBB (Developing)Rated limits ₹59.45 cr CARE rationale
22 Aug 2022 ₹100 cr raised through NCDs / bonds from ACTL
From the report

CARE Ratings takes note of the non-convertible debentures (NCD) of ₹100 crore raised by ACTL to fund the Phase-III and Phase-IV of acquisition and will continue to monitor the further acquisition process and its implication on ACTL’s credit profile.

CARE rationale
22 Aug 2022 Full repayment of NCDs
From the report

Negative factors – Factors that could lead to negative rating action/downgrade: • Non-completion of Phase-II of the acquisition by September 2023 or delay in refinancing of NCD. • Repayment of unsecured loans availed from the promoters before repayment of NCDs.

CARE rationale
22 Aug 2022 New borrowing arranged (NCDs / bonds)
From the report

Negative factors – Factors that could lead to negative rating action/downgrade: • Non-completion of Phase-II of the acquisition by September 2023 or delay in refinancing of NCD. • Repayment of unsecured loans availed from the promoters before repayment of NCDs.

CARE rationale
22 Aug 2022 Cash & liquid funds ₹90 cr
From the report

Liquidity: Stretched On a consolidated basis, ACTL’s cash and bank balances stood at around ₹90 crore as on March 31, 2022 (Prov.) against principal repayment obligations of around ₹22 crore for FY23.

CARE rationale
22 Aug 2022 Debt repayments due in FY23: ₹22 cr
From the report

Liquidity: Stretched On a consolidated basis, ACTL’s cash and bank balances stood at around ₹90 crore as on March 31, 2022 (Prov.) against principal repayment obligations of around ₹22 crore for FY23.

CARE rationale
22 Aug 2022 Cash & liquid funds ₹40 cr
From the report

Of the cash and bank balance, around ₹40 crore belongs to Mistral which ACTL may not have access to till the completion of the acquisition process and majority of balance amount would have been utilized towards margin money for BG of ₹65 crore.

CARE rationale
22 Aug 2022 Cash & liquid funds ₹15 cr
From the report

On a standalone basis, ACTL’s cash and bank balances stood at around ₹15 crore as on June 30, 2022.

CARE rationale
24 Jan 2022 CARE watch: BBB (Developing)Rated limits ₹92.81 cr CARE rationale
24 Jan 2022 Cash & liquid funds ₹3.67 cr
From the report

On standalone level, ACTL’s free cash and bank balances of Rs.3.67 Cr as of Sept’21 and ACAT’s cash and bank balances stood at Rs.11.39 Cr as of June 30, 2021.

CARE rationale
03 Nov 2020 CARE watch: BBB (Developing)Rated limits ₹198.72 cr CARE rationale
03 Nov 2020 Cash & liquid funds ₹65.3 cr
From the report

However, on consolidated level, the free cash and bank balances improved to Rs.65.3 Cr as of J une 30, 2020 (Rs.47.1 Cr as of March 31, 2020) on account of realization of receivables.

CARE rationale
03 Nov 2020 Cash & liquid funds ₹25.89 cr
From the report

On standalone level, ACET and ACAT had fr ee cash and bank balances of Rs.25.89 Cr and Rs.20.45 Cr respectively as of June 30, 2020.

CARE rationale
03 Nov 2020 New borrowing arranged (term loans)
From the report

ACET had availed the moratorium as a part of RBI’s Covid -19 package from March to August 2020 for deferment of interest and principal payments rel ated to term loan facilities and interest payments related to cash credit facility. 2 CARE Ratings Limited Press Release Analytical approach: ACET has established subsidiaries in various geographies and acts as on-shore centers and the business model entails a high amount of integration of ACET with its subsidiaries and therefore the consolidated approach is taken to analyze the credit profile of ACET.

CARE rationale
03 Jan 2020 CARE reaffirmed: BBB (Stable)Rated limits ₹209.44 cr CARE rationale
03 Jan 2020 Cash & liquid funds ₹47.3 cr
From the report

Liquidity: Adequate Company’s liquidity stands adequate with cash and bank balance of Rs.47.3 crore as on Sept’19 (Rs. 58.3 crore as on Mar’19) as against yearly term loan repayments of Rs. 20 crore.

CARE rationale
07 Feb 2019 CARE revised: BBB (Negative)Rated limits ₹109.88 cr CARE rationale
07 Feb 2019 Cash & liquid funds ₹31 cr
From the report

The company has adequate cash and bank balance of Rs. 31 crore as on Dec’18 though the same has declined from Rs.61.9 crore as on Mar’18.

CARE rationale
21 Aug 2018 CARE revised: BBB+ (Negative)Rated limits ₹86.75 cr CARE rationale
21 Aug 2018 Full repayment of loan
From the report

However the comfort is drawn from satisfactory cash and bank balance of the company and lower repayments of loan in FY19.

CARE rationale
05 Jan 2018 CARE watch: BBB+ (Stable)Rated limits ₹86.75 cr CARE rationale
05 Jan 2018 Cash & liquid funds ₹71.9 cr
From the report

Detailed description of the key rating drivers Key Rating Strengths Comfortable capital structure and liquidity The capital structure of Axiscades continues to remain comfortable with overall gearing of 0.30x as on Mar’17 (Mar’16: 0.33x) with high cash and bank balance of Rs. 71.9 crore.

CARE rationale
05 Jan 2018 Cash & liquid funds ₹105 cr
From the report

The total acquisition cost is estimated at Rs. 175 crore out of which Rs. 70 crore was paid as cash consideration while remaining Rs. 105 crore will be paid by way of allotment of shares of ACET.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeBLOCK C SECOND FLOOR KIRLOSKAR BUSINESS PARK, HEBBAL BANGALORE, BENGALURU, IN-KA, 560024
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Axiscades Technologies Limited

Competitors10identified
Locations4most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Infosys IT Services & Consulting · IT Services infosys.com 1981 India
Graphite India Limited Discovered Companies · Other Industries — — Kolkata, West Bengal, India
Larsen & Toubro Capital Goods & Power Equipment · Heavy Engineering & Capital Goods larsentoubro.com 1938 Mumbai, India
Wipro Part of Wipro. wipro.com 1945 India
Tata Consultancy Services Indian IT Services · IT Services & Software tcs.com 1968 Mumbai, India
HCL Technologies Indian IT Services · IT Services & Software hcltech.com 1991 New Delhi, India
Tech Mahindra IT Services & Consulting · IT Services techmahindra.com 1987 Mumbai, India
LTM Limited Indian IT Services · Business Services ltm.com 1997 Mumbai, Maharashtra, India
Bharat Heavy Electricals (BHEL) Capital Goods & Power Equipment · Heavy Engineering & Capital Goods bhel.com — India
Hindustan Aeronautics Limited Defence & Shipbuilding PSUs · Public Sector (PSU) & Government hal-india.co.in 1940 Bangalore, Karnataka, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.